Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulz, C.
Right arrow Articles by Pfeifer, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulz, C.
Right arrow Articles by Pfeifer, M.
(Chest. 2004;125:1706-1713.)
© 2004 American College of Chest Physicians

Activation of Bronchial Epithelial Cells in Smokers Without Airway Obstruction and Patients With COPD*

Christian Schulz, MD; Kirsten Krätzel; Konrad Wolf, PhD; Stephan Schroll, MD; Martina Köhler and Michael Pfeifer, MD

* From the Klinik und Poliklinik für Innere Medizin II, Bereich Pneumologie (Drs. Schulz, Wolf, and Schroll, and Ms. Krätzel, and Ms. Köhler), Klinikum der Universität Regensburg, Regensburg; and Klinik Donaustauf (Dr. Pfeifer), Donaustauf, Germany.

Correspondence to: Christian Schulz, MD, Medizinische Klinik und Poliklinik für Innere Medizin II, Klinikum der Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; e-mail: christian.schulz{at}klinik.uni-regensburg.de

Study objective: The aim of this study was to investigate the basal level as well as the tumor necrosis factor (TNF)-{alpha}- and interferon (IFN)-{gamma}-induced expression and release of the neutrophil chemoattractants interleukin (IL)-8 and growth-related oncogene (GRO)-{alpha} in primary bronchial epithelial cells (PBECs) from smokers without airflow obstruction and patients with COPD. In addition, the expression of both TNF-{alpha}-receptor subtypes—p55 TNF-receptor subtype (TNF-R55) and p75 TNF-receptor subtype (TNF-R75)—was quantified in PBECs.

Design: PBECs from eight smokers without airflow limitation and eight patients with COPD were stimulated with 50 ng/mL of TNF and 200 U/mL of IFN-{gamma} for 4 h along with unstimulated time controls. The transcriptional expression and protein release were quantitatively assessed by means of real-time polymerase chain reaction and enzyme-linked immunosorbent assay.

Results: Basal level messenger RNA (mRNA) expression and protein release of IL-8 and GRO-{alpha} were not significantly different between both groups, although a trend toward higher IL-8 levels was seen in patients with COPD. TNF-{alpha} induced significantly higher mRNA amounts of IL-8 (p = 0.005) and GRO-{alpha} (p = 0.007) in patients with COPD. This was accompanied by higher protein release data for IL-8 (p = 0.005) and GRO-{alpha} (p = 0.007). IFN-{gamma} had no significant effect on the mRNA expression and protein release of IL-8 and GRO-{alpha} in either group. TNF-R55 and TNF-R75 were detectable in PBECs. However, no significant differences were found between both groups with respect to steady-state mRNA levels of TNF-{alpha}-receptor subtypes.

Conclusion: PBECs from patients with COPD show significantly higher TNF-{alpha}-induced release of the neutrophil chemoattractant CXC-chemokines IL-8 and GRO-{alpha} compared to smokers without airflow limitation. This increased activation of PBECs may contribute to the predominance of neutrophils seen in the airway lumen of patients with COPD.

Key Words: bronchial epithelium • COPD • growth-related oncogene-{alpha} • interleukin-8 • smoking




This article has been cited by other articles:


Home page
ChestHome page
L. Farkas, M.-C. Hahn, M. Schmoczer, N. Jentsch, K. Kratzel, M. Pfeifer, and C. Schulz
Expression of CXC Chemokine Receptors 1 and 2 in Human Bronchial Epithelial Cells
Chest, November 1, 2005; 128(5): 3724 - 3734.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G H Bothamley
Smoking and tuberculosis: a chance or causal association?
Thorax, July 1, 2005; 60(7): 527 - 528.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes
Mediators of Chronic Obstructive Pulmonary Disease
Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, September 11, 2004; 329(7466): E323 - E323.
[Full Text] [PDF]


Home page
ChestHome page
A. Di Stefano, A. Capelli, and C. F. Donner
Role of Interleukin-8 in the Pathogenesis and Treatment of COPD
Chest, September 1, 2004; 126(3): 676 - 678.
[Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, August 14, 2004; 329(7462): E317 - E317.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
From the Library
Br. J. Ophthalmol., August 1, 2004; 88(8): 1104 - 1104.
[Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, July 10, 2004; 329(7457): 120 - 120.
[Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, May 22, 2004; 328(7450): 1268 - 1268.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Chest Physicians.